NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Bellerophon Therapeutics Inc (NASDAQ: BLPH)

 
BLPH Technical Analysis
5
As on 9th Jun 2023 BLPH STOCK Price closed @ 0.72 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.63 & Strong Sell for SHORT-TERM with Stoploss of 2.54 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BLPHSTOCK Price

Open 0.77 Change Price %
High 0.77 1 Day -0.05 -6.49
Low 0.72 1 Week -6.19 -89.58
Close 0.72 1 Month -6.85 -90.49
Volume 1262000 1 Year -2.14 -74.83
52 Week High 12.39 | 52 Week Low 0.67
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
BLPH
Daily Charts
BLPH
Intraday Charts
Whats New @
Bazaartrend
BLPH
Free Analysis
 
BLPH Important Levels Intraday
RESISTANCE0.82
RESISTANCE0.79
RESISTANCE0.77
RESISTANCE0.75
SUPPORT0.69
SUPPORT0.67
SUPPORT0.65
SUPPORT0.62
 
BLPH Forecast May 2024
4th UP Forecast3.46
3rd UP Forecast2.58
2nd UP Forecast2.04
1st UP Forecast1.49
1st DOWN Forecast-0.05
2nd DOWN Forecast-0.6
3rd DOWN Forecast-1.14
4th DOWN Forecast-2.02
 
BLPH Weekly Forecast
4th UP Forecast1.99
3rd UP Forecast1.58
2nd UP Forecast1.33
1st UP Forecast1.08
1st DOWN Forecast0.36
2nd DOWN Forecast0.11
3rd DOWN Forecast-0.14
4th DOWN Forecast-0.55
 
BLPH Forecast2024
4th UP Forecast23.67
3rd UP Forecast16.31
2nd UP Forecast11.76
1st UP Forecast7.21
1st DOWN Forecast-5.77
2nd DOWN Forecast-10.32
3rd DOWN Forecast-14.87
4th DOWN Forecast-22.23
 
 
BLPH Other Details
Segment EQ
Market Capital 32179232.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BLPH Address
BLPH
 
BLPH Latest News
 
Your Comments and Response on Bellerophon Therapeutics Inc
 
BLPH Business Profile
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its products include INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 2 clinical trial for the treatment of pulmonary hypertension associated with fibrotic interstitial lung disease; that has completed Phase 2a clinical trial for pulmonary hypertension associated with chronic obstructive pulmonary disease; and that is in Phase 2 dose escalation stage for pulmonary hypertension associated with sarcoidosis, as well as for chronic thromboembolic pulmonary hypertension, pulmonary hypertension associated with pulmonary edema from high altitude sickness, and COVID-19 patients. The company was formerly known as Ikaria Development LLC and changed its name to Bellerophon Therapeutics, Inc. in January 2014. Bellerophon Therapeutics, Inc. was founded in 2009 and is headquartered in Warren, New Jersey. Address: 184 Liberty Corner Road, Warren, NJ, United States, 07059
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service